Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
AffiliationDepartment of Respiratory Medicine, National Children's Hospital, Tallaght, Dublin 24. Peter.Greally@amnch.ie
Aspergillosis, Allergic Bronchopulmonary
Forced Expiratory Volume
MetadataShow full item record
CitationVoriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis. 2009, 102 (1):29 Ir Med J
JournalIrish medical journal
AbstractAllergic bronchopulmonary aspergillosis (ABPA) can cause a significant clinical deterioration in patients with cystic fibrosis. There is very little research in the current literature with regard to alternatives for treatment, apart from long courses of steroids. We conducted a retrospective review of all our patients with ABPA treated with the antifungal voriconazole and found there was a significant drop in IgE levels post treatment as well as a decrease in steroid dosing. The improvement in FEV was not statistically significant; however there was a very wide variation in pre-treatment levels.
- Voriconazole therapy in children with cystic fibrosis.
- Authors: Hilliard T, Edwards S, Buchdahl R, Francis J, Rosenthal M, Balfour-Lynn I, Bush A, Davies J
- Issue date: 2005 Dec
- Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
- Authors: Erwin GE, Fitzgerald JE
- Issue date: 2007 Dec
- [Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
- Authors: Bandrés Gimeno R, Muñoz Martínez MJ
- Issue date: 2007 Jan
- Life-threatening allergic bronchopulmonary aspergillosis in a well child with cystic fibrosis.
- Authors: Skowronski E, Fitzgerald DA
- Issue date: 2005 May 2
- [Rebound after ABPA treatment with voriconazole].
- Authors: Mulliez P, Croxo C, Saint-Georges FR
- Issue date: 2010 Sep